PlumeStars participated at the 4th International Meeting on “Inhaled therapies for tubercolosis and other infectious disease: products, technologies and procedures for efficiently treating pulmonary diseases” which was held on 16 and 17 October in Durham (NC).
This meeting focuses on tuberculosis and intends from TB therapy to translate products, technologies and procedures for efficiently treating the pulmonary infective diseases.
Paolo Colombo (CEO PlumeStars) gave a lecture as invited speaker and the topic of the talk was “The use of excipients to constract respirable antybiotic powders”.
He also presented the PlumeStars technology applied to Tobramycin, Amikacin and Colistimethate sodium.
